• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电子病历中的疾病与不耐受情况记录

Disease and intolerability documentation in electronic patient records.

作者信息

Buurma Henk, De Smet Peter A G M, Kruijtbosch Martine, Egberts Antoine C G

机构信息

SIR Institute for Pharmacy Practice Research, Leiden, Netherlands.

出版信息

Ann Pharmacother. 2005 Oct;39(10):1640-6. doi: 10.1345/aph.1G071. Epub 2005 Sep 13.

DOI:10.1345/aph.1G071
PMID:16159999
Abstract

BACKGROUND

Documentation of diseases and intolerabilities in electronic patient records (EPRs) in pharmacies is needed to produce an alert in case a contraindicated medicine is prescribed. Limited research is available concerning EPRs in pharmacies.

OBJECTIVE

To study the prevalence and quality of documentation of diseases and intolerabilities in EPRs in a sample of Dutch community pharmacies.

METHODS

Each participating pharmacy (N = 79) collected data on one day in May 2003 for each patient enrolled into the study (N = 687) concerning demographics, drug use, and documentation of diseases and intolerabilities.

RESULTS

In 57.4% of the EPRs, at least one disease and, in 7.9%, at least one intolerability was documented. Higher age, number of drugs used, and chronic disease score were associated with any documentation of a disease/intolerability in the EPR. The highest sensitivity scores (completeness) were found for diabetes (84.7%), asthma/chronic obstructive pulmonary disease (strict definition: 75.9%), and hypothyroidism (75.0%). Rather low values were found for prostatic hyperplasia (55.6%) and heart failure (29.4%). The positive predictive value (reliability) was high for hypothyroidism (100%) and diabetes (87.1%).

CONCLUSIONS

In a selection of Dutch pharmacies, at least one documented disease and/or intolerability was found in the EPR of almost 60% of the patients. Certain diseases were documented to a relatively high degree; others had poorer levels of documentation. For optimal surveillance of drug-disease interactions in pharmacies, the frequency and quality of disease and intolerability documentation need further improvement.

摘要

背景

为了在开具禁忌药物时发出警报,需要在药房的电子病历(EPR)中记录疾病和不耐受情况。关于药房电子病历的研究有限。

目的

研究荷兰社区药房样本中电子病历中疾病和不耐受情况记录的患病率和质量。

方法

每家参与的药房(N = 79)于2003年5月的一天收集了纳入研究的每位患者(N = 687)的人口统计学、药物使用以及疾病和不耐受情况记录的数据。

结果

在57.4%的电子病历中记录了至少一种疾病,7.9%的电子病历中记录了至少一种不耐受情况。年龄较大、使用药物数量较多以及慢性病评分较高与电子病历中记录任何疾病/不耐受情况相关。糖尿病(84.7%)、哮喘/慢性阻塞性肺疾病(严格定义:75.9%)和甲状腺功能减退(75.0%)的敏感性评分(完整性)最高。前列腺增生(55.6%)和心力衰竭(29.4%)的评分较低。甲状腺功能减退(100%)和糖尿病(87.1%)的阳性预测值(可靠性)较高。

结论

在荷兰的部分药房中,近60%患者的电子病历中发现了至少一种记录的疾病和/或不耐受情况。某些疾病的记录程度相对较高;其他疾病的记录水平较差。为了在药房中对药物 - 疾病相互作用进行最佳监测,疾病和不耐受情况记录的频率和质量需要进一步提高。

相似文献

1
Disease and intolerability documentation in electronic patient records.电子病历中的疾病与不耐受情况记录
Ann Pharmacother. 2005 Oct;39(10):1640-6. doi: 10.1345/aph.1G071. Epub 2005 Sep 13.
2
Documentation quality in community pharmacy: completeness of electronic patient records after patients' first visits.社区药店的文件质量:患者首次就诊后电子患者记录的完整性。
Ann Pharmacother. 2009 Nov;43(11):1787-94. doi: 10.1345/aph.1M242. Epub 2009 Oct 20.
3
Missed drug therapy alerts as a consequence of incomplete electronic patient records in Dutch community pharmacies.荷兰社区药店中因电子患者记录不完整而导致漏报药物治疗警报。
Ann Pharmacother. 2013 Oct;47(10):1272-9. doi: 10.1177/1060028013501992. Epub 2013 Oct 15.
4
Survey of drug-related problems identified by community pharmacies.社区药房发现的药物相关问题调查。
Ann Pharmacother. 2007 Nov;41(11):1825-32. doi: 10.1345/aph.1K207. Epub 2007 Oct 9.
5
Prevalence and determinants of pharmacy shopping behaviour.购药行为的患病率及决定因素。
J Clin Pharm Ther. 2008 Feb;33(1):17-23. doi: 10.1111/j.1365-2710.2008.00878.x.
6
Documentation and coding of ED patient encounters: an evaluation of the accuracy of an electronic medical record.急诊患者诊疗记录与编码:电子病历准确性评估
Am J Emerg Med. 2006 Oct;24(6):664-78. doi: 10.1016/j.ajem.2006.02.005.
7
Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records.利用药房记录评估老年人帕金森病的发病率和患病率。
Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):549-54. doi: 10.1002/pds.624.
8
Prevalence and patient awareness of selected potential drug interactions with self-medication.自我药疗中特定潜在药物相互作用的发生率及患者知晓情况。
J Clin Pharm Ther. 2007 Apr;32(2):149-59. doi: 10.1111/j.1365-2710.2007.00809.x.
9
Pharmacy data in epidemiological studies: an easy to obtain and reliable tool.流行病学研究中的药学数据:一种易于获取且可靠的工具。
Pharmacoepidemiol Drug Saf. 2002 Jul-Aug;11(5):379-84. doi: 10.1002/pds.722.
10
Management of drug-interaction alerts in community pharmacies.社区药房中药物相互作用警报的管理。
J Clin Pharm Ther. 2007 Apr;32(2):133-42. doi: 10.1111/j.1365-2710.2007.00802.x.

引用本文的文献

1
Electronic problem lists: a thematic analysis of a systematic literature review to identify aspects critical to success.电子问题清单:系统文献综述以确定成功关键因素的主题分析。
J Am Med Inform Assoc. 2018 May 1;25(5):603-613. doi: 10.1093/jamia/ocy011.
2
Completeness of patient records in community pharmacies post-discharge after in-patient medication reconciliation: a before-after study.患者出院后在社区药店进行用药重整后的患者记录完整性:一项前后对照研究。
Int J Clin Pharm. 2014 Aug;36(4):807-14. doi: 10.1007/s11096-014-9965-2. Epub 2014 Jun 11.
3
Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force.
目标设定在门诊药物安全:荷兰 HARM-Wrestling 工作组的建议。
Drug Saf. 2012 Mar 1;35(3):245-59. doi: 10.2165/11596000-000000000-00000.
4
Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011.比较患者和医疗保健提供者报告的口服降糖药不良事件发生率:1999 年至 2011 年发表的观察性研究的事后分析。
Drug Saf. 2011 Dec 1;34(12):1191-202. doi: 10.2165/11593810-000000000-00000.
5
A composite screening tool for medication reviews of outpatients: general issues with specific examples.一种用于门诊患者药物评估的综合筛查工具:一般问题及具体示例
Drugs Aging. 2007;24(9):733-60. doi: 10.2165/00002512-200724090-00003.